期刊文献+

柔性肽串联四价Aβ_(15)重组腺病毒的构建及纯化 被引量:2

Construction and purification of flexible peptide linked quadrivalent Aβ_(15) adenovirus
下载PDF
导出
摘要 目的构建并纯化含有柔性肽串联四价β-淀粉样蛋白(Aβ15)的重组腺病毒疫苗,用于老年性痴呆的预防和治疗。方法酶切获取带有IgGк轻链信号肽序列的柔性肽串联四价Aβ15基因,定向克隆于穿梭质粒pAdTrack-CMV中。通过与腺病毒骨架载体pAdeasy-1在细菌内同源重组形成重组腺病毒质粒pAd-4×Aβ15,转染人胚肾293细胞后包装成有感染能力的重组腺病毒颗粒(Ad-4×Aβ15)。Western检测4×Aβ15在培养液中的分泌表达。氯化铯密度梯度离心纯化重组腺病毒Ad-4×Aβ15。结果 pAdTrack-4×Aβ15测序结果和预期一致,同源重组并经293细胞包装后形成重组腺病毒Ad-4×Aβ15,western检测4×Aβ15在培养上清中表达。经氯化铯密度梯度离心纯化后Ad-4×Aβ15病毒颗粒数约为4.6×1012 VP/mL。结论成功制备了重组腺病毒Ad-4×Aβ15,感染细胞证实其呈分泌表达,经氯化铯密度梯度离心纯化后得到高滴度的重组腺病毒。为老年性痴呆(Alzheimer’s disease,AD)的实验治疗打下基础。 Objective To construct and purify the flexible peptide linked quadrivalent Aβ15 Adenovirus vaccine for preventing and therapy of the Alzheimer disease(AD).Methods The IgG к light chain fused flexible peptide linked quadrivalent Aβ15 sequence was acquired by restricted enzyme digestion.And it was cloned to the shuttle plasmid pAdTrack-CMV.The homologous recombination between the recombinant vector and the adenovirus bone vector pAdeasy-1 in the Ecoli BJ5183 resulted to the formation of recombinant adenovirus vector pAd-4×Aβ15.The infecting recombinant virus particles Ad-4×Aβ15 was produced after the recombinant adenovirus vector had been transfected to the human embry kidney 293 cells.Western blotting detected the secreted expression of 4×Aβ15 protein in the supernatant.Ad-4×Aβ15 was purified by CsCl2 density gradient ultracentrifuge.Results The sequence results of pAdTrack-4×Aβ15 were consistent with expectancy.After homologous recombination and packaging with 293 cells,the recombinant Ad-4×Aβ15 adenovirus was obtained.Western blotting suggested that the 4×Aβ15 protein was expressed secretly in the supernatant.After CsCl2 density gradient ultracentrifuge,the particles of Ad-4×Aβ15 adenovirus were about 4.6×1012 VP/mL.Conclusions The Ad-4×Aβ15 was constructed successfully.It is confirmed that the secreted interest proteins were expressed in the infected cells.After CsCl2 density gradient ultracentrifuge,the high titre Ad-4×Aβ15 adenovirus were obtained,which is important for AD experimental therapy.
出处 《解剖学研究》 CAS 2010年第6期426-430,共5页 Anatomy Research
基金 国家自然科学基金(81000545) 广东省自然科学基金(9451008901002145) 教育部高等学校博士学科点专项科研基金(20090171120047) 广东省医学科研基金(B2010066) 广州市科技计划项目(10C32060117) 广州市教育局科技计划项目(08A040) 广东省科技社会发展计划项目(2010B031600070 2006B36004001)
关键词 Β-淀粉样蛋白 串联重复 重组腺病毒 阿尔茨海默病 β-amyloid Tandem repeat Recombinant adenovirus Alzheimer disease
  • 相关文献

参考文献11

  • 1Schenk D,Barbour R,Dunn W,et al.Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.Nature,1999,400(6740):173-177.
  • 2Schenk D.Amyloid-beta immunotherapy for Alzheimer's disease:the end of the beginning.Nat Rev Neurosci,2002,3(10):824-828.
  • 3Serrano-Pozo A,William CM,Ferrer I,et al.Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology.Brain,2010,133(Pt 5):1312-1327.
  • 4邹俊涛,袁茂运,杨俊华,李少阳,夏宇岑,袁群芳,姚志彬.Aβ_(15)老年性痴呆疫苗接种小鼠的剂量优化研究[J].解剖学研究,2010,32(3):161-164. 被引量:2
  • 5Zeng M,Smith SK,Siegel F,et al.AdEasy system made easier by selecting the viral backbone plasmid preceding homologous recombination.Biotechniques,2001,31(2):260-262.
  • 6Kim HD,Jin JJ,Maxwell JA,et al.Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease.Immunol Lett,2007,112(1):30-38.
  • 7Asuni AA,Boutajangout A,Scholtzova H,et al.Vaccination of Alzheimer's model mice with Abeta derivative in alum adjuvant reduces Abeta burden without microhemorrhages.Eur J Neurosci,2006,24(9):2530-2542.
  • 8Kim HD,Tahara K,Maxwell JA,et al.Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Abeta1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease.J Gene Med,2007,9(2):88-98.
  • 9Seabrook TJ,Thomas K,Jiang L,et al.Dendrimeric Abeta1-15 is an effective immunogen in wildtype and APP-tg mice.Neurobiol Aging,2007,28(6):813-823.
  • 10Maier M,Seabrook TJ,Lemere CA.Developing novel immunogens for an effective,safe Alzheimer's disease vaccine.Neurodegener Dis,2005,2(5):267-272.

二级参考文献16

  • 1张革,汪华侨,邹俊涛,李国营,袁群芳,林贤,姚志彬,张革.Aβ_(1-15)多价DNA疫苗的构建及其对体液免疫的效果[J].中山大学学报(医学科学版),2005,26(4):371-376. 被引量:5
  • 2李国营,汪华侨,胡金家,徐杰,姚志彬.Aβ_(1-15)肽疫苗接种改善AD转基因模型Tg2576鼠的学习记忆能力[J].解剖学研究,2006,28(2):83-85. 被引量:2
  • 3Strauss ME,Sperry SD.An informant-based assessment of apathy in Alzheimer disease.Neuropsychiatry Neuropsychol Behav Neurol,20 02,15(3):176-183.
  • 4Schenk D,Barbour R,Dunn W,et al.Immunization with amyloid-beta attenuates Alzheimer-diseaselike pathology in the PDAPP mouse.Nature,1999,400(6740):173-177.
  • 5Zou J,Yao Z,Zhang G,et al.Vaccination of Alzheimer's model mice with adenovirus vector containing quadrivalent foldable Abeta(1-15) reduces Abeta burden and behavioral impairment without Abeta-specific T cell response.J Neurol Sci,2008,272(1-2):87-98.
  • 6Serrano-Pozo A,William CM,Ferrer I,et al.Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology.Brain,2010,133(Pt 5):1312-1327.
  • 7Senior K.Dosing in phase Ⅱ trial of Alzheimer's vaccine suspended.Lancet Neurol,2002,1(1):3.
  • 8Nicoll JA,Wilkinson D,Holmes C,et al.Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide:a case report.Nat Med,2003,9(4):448-452.
  • 9Gandy S.Testing the amyloid hypothesis of Alzheimer's disease in vivo.Lancet Neurol,9(4):333-335.
  • 10Li H,Zou J,Yao Z,et al.Tetravalent Aβ1-15 vaccine reduces TCR-positive cell infiltration and up-regulates p75 in Tg2576 brains compared to Aβ42 vaccine.J Neuroimmunol,2010,219(1-2):8-16.

共引文献1

同被引文献18

  • 1杨志勇,汪华侨,张革,林贤,谢瑶,袁群芳,姚志彬.国人外周血抗β-淀粉样蛋白抗体水平的依龄性变化[J].中山大学学报(医学科学版),2005,26(2):125-128. 被引量:8
  • 2刘莹,张微微.脑淀粉样血管病的研究现状[J].中华老年心脑血管病杂志,2007,9(1):65-67. 被引量:14
  • 3Shinoda Y, Sadakata T, Nakao K, et al. Calcium-dependent activator protein for secretion 2 (CAPS2) promotes BDNF secretion and is critical for the development of GABAergic intemeuron network. Proc Nail Acad Sci U S A, 2010, PMID-21173225.
  • 4Shono Y, Yokota C, Kuge Y, et al. Gene expression associated with an enriched environment after transient focal ischemia. Brain Res, 2010, PMID-21185809.
  • 5Barde YA, Edgar D, Thoenen H. Purification of a new neurotrophic factor from mammalian brain. Embo J, 1982,1 (5) :549-553.
  • 6Murray M, Kim D, Liu, et al. Transplantation of genetically modified cells contributes to repair and recovery from spinal injury. Brain Res Brain Res Rev, 2002,40(1-3) :292-300.
  • 7Chow SY, Moul J, Tobias CA, et al. Characterization and intraspinal grafting of EGF/bFGF-dependent neurospheres derived from embryonic rat spinal cord. Brain Res, 2000,874(2) :87-106.
  • 8Petridis AK,Barth H,Buhl R,et al.Outcome of cerebral amyloid angiopathic brain haemorrhage.Acta Neurochir(Wien),2008,150:889-895.
  • 9Viswanathan A,Greenberg SM.Cerebral amyloid angiopathy in the elderly.Ann Neurol,2011,70:871-880.
  • 10DeMattos RB,Bales KR,Cummins DJ,et al.Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease.Proc Natl Acad Sci U S A,2001,98:8850-8855.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部